Industry NewsHorizon Discovery extends gene modulation portfolio with industry-first synthetic sgRNA and patent pending dCas9 repressor for CRISPRi
Industry NewsCytosurge’s FluidFM technology facilitates multiplex CRISPR editing and monoclonal cell line development in less than three weeks